E
BioCardia, Inc. BCDA
$2.31 $0.13956.43% NASDAQ
Recommendation
Prev Close
$2.17
Volume
26,979
Avg Vol (90D)
73,485
Market Cap
$11.24M
Dividend & Yield
--
52-Week Range
$1.63 - $5.04
P/E (TTM)
--
EPS (TTM)
-$3.08
My Lists My Alerts
Access our Premium Ratings
Get Access
Rating
Reward
Risk
Rating Factors
Growth Index
Efficiency Index
Solvency Index
Total Return Index
Volatility Index
Dividend Index
Headlines
BioCardia, Inc. (NASDAQ:BCDA) Short Interest Down 49.9% in May
6/1/2025 - Ticker Report
BioCardia (NASDAQ:BCDA) Trading 3.7% Higher - Still a Buy?
5/28/2025 - Ticker Report
BioCardia to Participate in Fireside Chat at A.G.P. ...
5/21/2025 - GuruFocus
BioCardia to Participate in Fireside Chat at A.G.P. ...
5/21/2025 - GuruFocus
BioCardia to Participate in Fireside Chat at A.G.P. Virtual Healthcare Company Showcase on May 21, 2025
5/21/2025 - Globe Newswire
Analysts Are Bullish on Top Healthcare Stocks: Akero Therapeutics (AKRO), BioCardia (BCDA)
5/15/2025 - TipRanks Financial Blog
BioCardia Inc (BCDA) Q1 2025 Earnings Call Highlights: Progress in Cardiac Cell Therapy Amid ...
5/15/2025 - GuruFocus
Q1 2025 BioCardia Inc Earnings Call Transcript
5/15/2025 - GuruFocus
BioCardia, Inc. (BCDA) Q1 2025 Earnings Call Transcript
5/14/2025 - Seeking Alpha: Transcripts
BioCardia, Inc. (BCDA) Q1 2025 Earnings Call Transcript
5/14/2025 - SeekingAlpha
BioCardia Reports First Quarter 2025 Business Highlights and Financial Results
5/14/2025 - GuruFocus
BioCardia Reports First Quarter 2025 Business Highlights and Financial Results
5/14/2025 - Globe Newswire
BioCardia to Host Q1 2025 Corporate Update and Financial Results Conference Call on May 14, ...
5/9/2025 - GuruFocus
BioCardia to Host Q1 2025 Corporate Update and Financial Results Conference Call on May 14, 2025
5/9/2025 - GuruFocus
BioCardia to Host Q1 2025 Corporate Update and Financial Results Conference Call on May 14, 2025
5/9/2025 - Globe Newswire
Insider Buying Surges in May. Especially These 5 Stocks
5/7/2025 - 24/7 Wall St.
BioCardia (BCDA) Expands Enrollment for Phase 3 CardiAMP HF II Trial BCDA Stock News
5/6/2025 - GuruFocus
BioCardia initiates patient enrollment at University of Wisconsin for study
5/6/2025 - The Fly
BioCardia Initiates Patient Enrollment at University of Wisconsin at Madison for Ongoing ...
5/6/2025 - GuruFocus
BioCardia Initiates Patient Enrollment at University of Wisconsin at Madison for Ongoing CardiAMP HF II Pivotal Study
5/6/2025 - Globe Newswire
BioCardia (BCDA) Moves Forward With Phase III CardiAMP HF II Trial BCDA Stock News
5/1/2025 - GuruFocus
BioCardia Announces First Patient in Phase 3 Randomized Controlled Double-Blind CardiAMP HF II ...
5/1/2025 - GuruFocus
BioCardia announces first patient enrolled in Phase III CardiAMP HF II trial
5/1/2025 - The Fly
BioCardia Announces First Patient in Phase 3 Randomized Controlled Double-Blind CardiAMP HF II Clinical Trial of the Company's Lead Cell Therapy for Treatment of Heart Failure
5/1/2025 - Globe Newswire
BioCardia files to sell 813,636 shares of common stock for holders
4/30/2025 - SeekingAlpha.com: All News
Income Statement
Total Revenue (TTM)
$3.00K
EBITDA (TTM)
-$8.39M
EBIT (TTM)
-$8.45M
Net Income (TTM)
-$8.39M
Balance Sheet
Total Assets (Q)
$2.17M
Total Debt (Q)
$850.00K
Total Liabilities (Q)
$3.69M
Book Value Per Share (Q)
-$0.3246
Cash Flow
Cash from Operations (TTM)
-$8.11M
Cash from Investing (TTM)
-$6.00K
Cash from Financing (TTM)
$8.12M
Net Change in Cash (TTM)
$0.00
Filings
Filing Date
Wednesday, May 14, 2025
Period Date
Monday, March 31, 2025
Next Filing
Week of Aug 11 and 15 (est)
Price History
Loading...
Beta
1.90
7-Day Total Return
6.70%
30-Day Total Return
17.26%
60-Day Total Return
-10.12%
90-Day Total Return
-2.94%
Year to Date Total Return
2.21%
1-Year Total Return
-37.90%
2-Year Total Return
-92.26%
3-Year Total Return
-90.49%
5-Year Total Return
-95.95%
52-week Low
Dec 19, 2024 - $1.63
52-week High
Jun 07, 2024 - $5.04
Valuation
Market Cap
$11.24M - Nano Cap
Enterprise Value
$11.14M
Price/Sales (TTM)
3,617.50
Price/Book (Q)
-6.69
Dividends and Shares
Shares Outstanding
4.64M
Dividend Per Share (Most Recent)
--
Dividend Per Share (TTM)
--
Corporate Info
Website
www.biocardia.com
Phone Number
650 226 0120
Address
320 Soquel Way
Sunnyvale, CA 94085
Country
United States
Year Founded
--
Business Description
Sector
Health Care
Industry
Pharmaceuticals, Biotechnology and Life Sciences
BioCardia, Inc., a clinical-stage regenerative medicine company, develops cellular and cell-derived therapeutics for cardiovascular and pulmonary diseases in the United States. The company’s lead... more
NASDAQ 06/09/2025 12:08PM Eastern Quotes delayed